Subscribe
 
Bookmark and Share
Subscribe via RSS Join us on Facebook Follow us on Twitter Subscribe via Email

Active Chemicals in Cannabis Inhibits Prostate Cancer Cell Growth

cannabis According to researchers, active chemicals in cannabis inhibits prostate cancer cell growth.

Prostate cancer is the most common cancer in men in the UK, affecting more than 35,000 men in the UK each year. An estimated 192,280 new cases of prostate cancer will occur in the US during 2009. A quarter of all new cases of cancer diagnosed in men are prostate cancers.

The researchers tested the effects of the active chemicals in cannabis called cannabinoids on three human prostate cancer cell lines - called PC-3, DU-a45 and LNCaP.

The prostate cancer cells carry molecular ‘garages’, called receptors, in which cannabinoids can 'park'.

The scientists showed for the first time that if cannabinoids ‘park’ on a receptor called CB2, the cancer cells stop multiplying.

But Dr Lesley Walker, Cancer Research UK's director of cancer information warned patients against smoking the drug. She said: "It absolutely isn’t the case that men might be able to fight prostate cancer by smoking cannabis."

Dr Walker added: "This research suggest that prostate cancer cells might stop growing if they are treated with chemicals found in cannabis but more work needs to be done to explore the potential of the cannabinoids in treatment."

To confirm the findings the scientists switched off the CB2 receptors on the prostate cells. When cannabinoids were then added to cells without the CB2 receptor, the prostate cancer cells carried on dividing and growing. This suggests that cannabinoids connect with the CB2 receptors on prostate cancer cells to stop cell division and spread.

Professor Ines Diaz-Laviada, study author said: "Our research shows that there are areas on prostate cancer cells which can recognize and talk to chemicals found in cannabis called cannabinoids. These chemicals can stop the division and growth of prostate cancer cells and could become a target for new research into potential drugs to treat prostate cancer."

Related Articles

prostate-2.jpg
Although other studies have provided conflicting results (Ejaculation Frequency and Prostate Cancer Risk), according to a study of more than 800 men who are very
vitamin-c.jpg
Serious flaws in a recent study, which concluded that high doses of vitamin C reduce the effectiveness of chemotherapeutic drugs in the treatment of cancer, are
sodas.jpg
Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft
male-pelvic-anatomy.jpg
According to a recent study led by Dr Polyxeni Dimitropoulou and researchers at the University of Nottingham, men who are very sexually active in their twenties and
brocoli.jpg
One of the American Cancer Society's key dietary recommendations to reduce the risk of cancer is to include cruciferous vegetables such as broccoli. Sulforaphane is

References:
1. N Olea-Herrero, D Vara, S Malagarie-Cazenave, I Díaz-Laviada. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2. British Journal of Cancer, doi:10.1038/sj.bjc.6605248.
2. Cancer Research UK.
3. American cancer Society.

Add comment


Security code
If you cannot read the code click to refresh for a new code.

FEATURED FOOD
Health Benefits Radishes

FREE TOOLS
FEATURED VIDEO
What is Alzheimer's?

Truth About Abs



Banner Nuts Online Vita Muffin